MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$620.48
+4.21%Price chart
Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15
Key dataSep 15, 2026
Open$594.30
From 52W high−0.04%
Volume256773.00
Market cap$17.32B
P/E (TTM)35.7x
P/S (TTM)6.2x
Div yield—
Key dataSep 15, 2026
Open
$594.30
From 52W high
−0.04%
Volume
256773.00
Market cap
$17.32B
ValuationView details →
P/E (Fwd)
33.8x
EV/EBITDA
28.1x
P/E (TTM)
35.7x
RSI (14)
63.1
MomentumView details →
1D Return
+4.21%
YTD Return
+10.12%
SummaryUpdated Jun 1, 2026
Medpace Holdings, Inc. (NASDAQ:MEDP) is a Cincinnati-based contract research organization (CRO) founded in 1992 that provides clinical trial services to pharmaceutical, biotechnology, and medical device companies. The company went public in August 2016 and has established itself as a specialized CRO focused primarily on serving biotech clients through the complete clinical development process from Phase I through Phase IV trials across various therapeutic areas.
Similar companies
Latest newsMore news →
Medpace (MEDP) shares closed at $595.41, up 1.34% from the previous day, while the broader market fell.1d agoMedpace reported second-quarter earnings that beat expectations.20d agoMedpace Holdings raised its 2026 revenue guidance to a midpoint of $2.85 billion during its second-quarter earnings call.33d ago